Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Dan and Sharon Moceri
Grant: 5DP5OD021356-05
NCI NIH HHS
Grant: R01 CA222695
NINDS NIH HHS
Grant: R01 NS110703
Dan and Sharon Moceri
Grant: P30CA060553
NIH HHS
Grant: DP5 OD021356
NINDS NIH HHS
Grant: K08 NS092912
NINDS NIH HHS
Grant: R01 NS112712
Brain Tumor Funders' Collaborative
Grant: R01CA222695-01
National Institute of Neurological Disorders and Stroke
Grant: R01NS112712–01
Parker Institute for Cancer Immunotherapy
Grant: U54CA199090
Dan and Sharon Moceri
Grant: 1R01NS110703-01A1
NCI NIH HHS
Grant: P50 CA211015
NCI NIH HHS
Grant: P50 CA221747
Damon Runyon Cancer Research Foundation
Grant: K08NS092912-05
FWCI
2.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals